Robeco Institutional Asset Management B.V. lessened its holdings in Amdocs Limited (NASDAQ:DOX - Free Report) by 1.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 520,709 shares of the technology company's stock after selling 8,615 shares during the quarter. Robeco Institutional Asset Management B.V. owned 0.46% of Amdocs worth $44,333,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently bought and sold shares of DOX. Squarepoint Ops LLC bought a new stake in shares of Amdocs in the 2nd quarter worth about $2,114,000. Millennium Management LLC grew its holdings in shares of Amdocs by 11.7% in the 2nd quarter. Millennium Management LLC now owns 45,804 shares of the technology company's stock worth $3,615,000 after purchasing an additional 4,815 shares during the last quarter. Susquehanna Fundamental Investments LLC lifted its position in Amdocs by 143.0% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 22,068 shares of the technology company's stock worth $1,742,000 after buying an additional 12,987 shares in the last quarter. Creative Planning lifted its position in Amdocs by 122.9% during the 2nd quarter. Creative Planning now owns 11,007 shares of the technology company's stock worth $869,000 after buying an additional 6,069 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. lifted its position in Amdocs by 24.8% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 2,215 shares of the technology company's stock worth $175,000 after buying an additional 440 shares in the last quarter. Institutional investors own 92.02% of the company's stock.
Amdocs Stock Performance
Amdocs stock traded up $1.03 during mid-day trading on Thursday, hitting $87.34. 111,148 shares of the company's stock traded hands, compared to its average volume of 507,540. The firm has a 50 day simple moving average of $85.82 and a two-hundred day simple moving average of $86.25. Amdocs Limited has a fifty-two week low of $74.41 and a fifty-two week high of $94.04. The stock has a market cap of $9.86 billion, a price-to-earnings ratio of 20.60, a P/E/G ratio of 1.42 and a beta of 0.71. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.20 and a quick ratio of 1.20.
Amdocs Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.479 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.19%. The ex-dividend date is Tuesday, December 31st. Amdocs's dividend payout ratio is currently 45.28%.
Analyst Ratings Changes
A number of brokerages recently weighed in on DOX. StockNews.com downgraded shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, January 14th. Barclays decreased their target price on shares of Amdocs from $113.00 to $111.00 and set an "overweight" rating for the company in a research note on Thursday, November 14th. Stifel Nicolaus assumed coverage on shares of Amdocs in a research note on Wednesday, October 2nd. They issued a "buy" rating and a $100.00 target price for the company. Finally, Oppenheimer raised their target price on shares of Amdocs from $98.00 to $105.00 and gave the company an "outperform" rating in a research note on Wednesday, November 13th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, Amdocs has an average rating of "Moderate Buy" and a consensus target price of $101.20.
View Our Latest Stock Analysis on Amdocs
Amdocs Company Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Stories
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.